INTERLEUKIN-6 PRODUCTION BY MURINE B-CELLS AND B-CELL LINES

被引:23
作者
HOBBS, MV [1 ]
MCEVILLY, RJ [1 ]
KOCH, RJ [1 ]
CARDENAS, GJ [1 ]
NOONAN, DJ [1 ]
机构
[1] LIGAND PHARMACEUT, SAN DIEGO, CA 92121 USA
关键词
D O I
10.1016/0008-8749(91)90041-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have analyzed interleukin (IL)-6 gene transcription and IL-6 secretion by murine B cells in vitro. Mitogenic doses of lipopolysaccharide (LPS) or LPS in combination with F(ab′)2 goat anti-mouse IgM antibodies (GAMμ), but not GAMμ alone, induced B cells to synthesize and release IL-6. In time course experiments, the accumulation of IL-6 mRNA was first detectable at 24-36 hr of culture and the levels were maintained through 60 hr; these kinetics correlated well with increases in supernatant IL-6 levels and were coincident with vigorous cell cycle activity. We also analyzed constitutive and LPS-induced IL-6 gene expression by the murine B cell lines: 70Z/3, 38C-13, WEHI-231, X16C, WEHI-279, and BCL1. Only the WEHI-279 and BCL1 lines produced detectable IL-6 constitutively, and the BCL1 cells could be further induced by treatment with LPS. Of the remaining cell lines, only WEHI-231 and X16C could be stimulated with LPS to produce IL-6. To evaluate whether IL-6 could influence proliferation and Ig secretion by the cell lines, low cell density cultures were established in the presence of various doses of human rIL-6 and were assessed over time for levels of [3H]thymidine uptake and supernatant Ig. Under these conditions, IL-6 had no effect on either cell function. © 1991.
引用
收藏
页码:442 / 450
页数:9
相关论文
共 37 条
  • [31] TAKATSUKI F, 1988, J IMMUNOL, V141, P3072
  • [32] GROWTH AUTONOMY AND TUMORIGENICITY OF INTERLEUKIN-6-DEPENDENT B-CELLS TRANSFECTED WITH INTERLEUKIN-6 CDNA
    TOHYAMA, N
    KARASUYAMA, H
    TADA, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (02) : 389 - 400
  • [33] MONOCYTE-DERIVED HUMAN B-CELL GROWTH-FACTOR IDENTIFIED AS INTERFERON-BETA-2 (BSF-2, IL-6)
    TOSATO, G
    SEAMON, KB
    GOLDMAN, ND
    SEHGAL, PB
    MAY, LT
    WASHINGTON, GC
    JONES, KD
    PIKE, SE
    [J]. SCIENCE, 1988, 239 (4839) : 502 - 504
  • [34] VANSNICK J, 1988, EUR J IMMUNOL, V18, P193
  • [35] INTERLEUKIN-HP1, A T-CELL-DERIVED HYBRIDOMA GROWTH-FACTOR THAT SUPPORTS THE INVITRO GROWTH OF MURINE PLASMACYTOMAS
    VANSNICK, J
    VINK, A
    CAYPHAS, S
    UYTTENHOVE, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) : 641 - 649
  • [36] INTERLEUKIN-6 - AN OVERVIEW
    VANSNICK, J
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 : 253 - 278
  • [37] B-CELL GROWTH AND DIFFERENTIATION ACTIVITY OF INTERLEUKIN-HP1 AND RELATED MURINE PLASMACYTOMA GROWTH-FACTORS - SYNERGY WITH INTERLEUKIN-1
    VINK, A
    COULIE, PG
    WAUTERS, P
    NORDAN, RP
    VANSNICK, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (04) : 607 - 612